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Abstract 
Background Determining the peak growth velocity of a patient with adolescent idiopathic 
scoliosis (AIS) is important for timely treatment to prevent curve progression. It is important to 
be able to predict when the curve-progression risk is greatest to maximize the benefits of any 
intervention for AIS. The distal radius and ulna (DRU) classification has been shown to 
accurately predict skeletal growth. However, its utility in predicting curve progression and the 
rate of progression in AIS is unknown. 
Questions/purposes (1) What is the relationship between radius and ulna grades to growth rate 
(body height and arm span) and curve progression rate? (2) When does peak curve progression 
occur in relation to peak growth rate as measured by months and by DRU grades? (3) How many 
months and how many DRU grades elapse between peak curve progression and plateau?  
Methods This was a retrospective analysis of a longitudinally maintained dataset of growth and 
Cobb angle data of patients with AIS who presented with Risser Stages 0 to 3 and were followed 
to maturity at Risser Stage 5 at a single institute with territory-wide school screening service. 
From June 2014 to March 2016, a total of 513 patients with AIS fulfilled study inclusion criteria. 
Of these, 195 were treated with bracing at the initial presentation and were excluded. A total of 
318 patients with AIS (74% girls) with a mean age of 12 ± 1.5 years were studied.  For analysis, 
only data from initial presentation to commencement of intervention were recorded. Data for 
patients during the period of bracing or after surgery were not used for analysis to eliminate 
potential interventional confounders. Of these 318 patients, 192 were observed, 119 were braced, 
and seven underwent surgery.  Therefore 192 patients (60.4%) who were observed were 
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followed up until skeletal maturity at Risser Stage 5; no patients were lost to followup. The mean 
curve magnitude at baseline was 21.6o ± 4.8o. Mean followup before commencing intervention or 
skeletal maturity was 4.3 ± 2.3 years. Standing body height, arm span, curve magnitude, Risser 
stage, and DRU classification were studied. A subgroup analysis of 83 patients inclusive of 
acceleration, peak and deceleration progression phases for growth and curve progression was 
studied to determine any time lag between growth and curve progression. Results were described 
in mean ± SD. 
Results There was positive correlation between growth rate and curve progression rate for body 
height (r = 0.26; p < 0.001) and arm span (r = 0.26; p < 0.001). Peak growth for body height 
occurred at radius grade (R) 6 (0.56 ± 0.29 cm/month) and ulna grade (U) 4 (0.65 ± 0.31 
cm/month); peak change in arm span occurred at R5 (0.67 ± 0.33 cm/month) and U3 (0.67 ± 
0.22 cm/month); and peak curve progression matched with R7 (0.80 ± 0.89 cm/month) and U5 
(0.84 ± 0.78 cm/month). Subgroup analysis confirmed that peak curve progression lagged behind 
peak growth rate by approximately 7 months or 1 DRU grade. The mean time elapsed between 
the peak curve progression rate and the plateau phase at R9 U7 was approximately 16 months, 
corresponding to two DRU grades.  
Conclusions By using a standard skeletal maturity parameter in the DRU classification, this 
study showed that the maximal curve progression occurs after the peak growth spurt, suggesting 
that the curve should be monitored closely even after peak growth. In addition, the period of 
potential curve continuing progression extends nearly 1.5 years beyond the peak growth phase 
until skeletal maturity. Future studies may evaluate whether by observing the trend of growth 
and curve progression rates, we can improve the outcomes of interventions like bracing for AIS.  
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Level of Evidence Level II, prognostic study. 
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Introduction 
The main aim of treating patients with adolescent idiopathic scoliosis (AIS) who are skeletally 
immature is to prevent curve progression during growth [27]. Bracing is a commonly used 
treatment option initiated in adolescence to reduce the chances for adulthood curve progression 
[27-29]. Appropriate timing of bracing before the peak height velocity has been shown to 
prevent curves from reaching the surgical threshold, but only with good compliance [21, 22, 28]. 
In what is considered the “landmark” bracing study by Weinstein et al. [28], only 75% and 42% 
of patients experience treatment success with bracing and observation, respectively. This 
suggests that some patients with AIS experience deterioration even with bracing and some do not 
benefit from any treatment. However, there is limited information regarding the period of 
bracing and timing of weaning with success of curve control, particularly with reference to 
currently used growth parameters. The key parameter clinicians use to determine whether a 
patient with AIS may benefit from bracing is the remaining growth potential. To improve 
treatment outcomes, determining the peak height velocity is necessary to indicate when the risk 
for deformity progression is greatest and hence the period when brace treatment is most needed 
[9, 13, 28]. Many known radiographic parameters have been developed to aid in predicting peak 
height velocity of the long bones [4, 10, 17-19, 24]. A correlation between curve acceleration 
with timing of peak height velocity was identified by these studies but is highly variable and has 
limited utility for clinical decision-making. Thus, even with accurate prediction of growth rates, 
there are still difficulties in predicting when and how each patient might deteriorate regarding 
different growth phases.  
The current limitations in knowledge of the relationship between growth and curve progression 
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patterns in patients with AIS require attention. Epiphyseal capping as described by Sanders et al. 
[ ] tells us it is the time of peak height velocity but not necessarily the peak curve progression 
velocity. By predicting more accurately when the curve progression risk is greatest with 
reference to a patient’s growth potential is necessary to maximize the benefits of any 
intervention. This can be determined by assessing how growth and curve progression rates match 
in patients with AIS. The distal radius and ulna (DRU) classification is a tested and validated 
maturity parameter, which has shown accuracy in predicting the peak growth and growth 
cessation [4-6]. It is simple to use and can encompass the entire period of adolescent growth 
necessary for AIS management. It has been compared and found superior to Risser staging and 
metacarpal and phalangeal complexes regarding peak height velocity prediction [4]. However, its 
utility for predicting curve progression is still unclear. 
Therefore, we asked: (1) What is the relationship between radius and ulna grades to growth rate 
(body height and arm span) and curve progression rate? (2) When does peak curve progression 
occur in relation to peak growth rate, as measured by months and by DRU grades? (3) How 
many months and how many DRU grades elapse between peak curve progression and plateau?  
Patients and Methods 
We performed a retrospective study based on longitudinally maintained data collected since May 
1998 from a tertiary scoliosis specialty clinic. This is one of two clinics receiving referrals from 
a territory-wide school screening service. All patients with AIS followed up in our clinic from 
June 2014 to March 2016 who presented with Risser stages of 0 to 3, less than 2 years 
postmenarche, and followed until skeletal maturity at Risser Stage 5 were included in this study. 
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Exclusion criteria were patients with nonidiopathic scoliosis and AIS who were treated with 
bracing or surgery before our initial assessment. The local institutional review board 
(Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong 
West Cluster UW 14-613) approved this study. 
A total of 513 patients with AIS fulfilled study inclusion criteria (Fig. 1). Of these, 195 were 
treated with bracing at the initial presentation and were excluded for analysis. A total of 318 
patients remained for analysis (Table 1). This included 236 girls (74%) and 82 boys (26%) with a 
mean age of 12 ± 1.3 years (girls) and 13 ± 1.6 years (boys) at initial presentation. The baseline 
curve magnitude was 22° ± 5°. The mean duration of followup before commencing intervention 
or reaching skeletal maturity was 4.3 ± 2.3 years. For analysis, only data from initial presentation 
to commencement of intervention were recorded. Data for patients during the period of bracing 
or after surgery were not used for analysis to eliminate potential interventional confounders. Of 
these 318 patients, 192 were observed, 119 were braced, and seven underwent surgery at the end 
of followup. Therefore 192 patients (60.4%) who were observed without intervention had 
complete data until skeletal maturity at Risser Stage 5. None of the patients under study were lost 
to followup.  
Subgroup Analyses 
Of the original 318 patients, 83 who had data for acceleration, peak, and deceleration progression 
in growth and curve progression rates, underwent subgroup analysis to determine the variance in 
DRU grade and age for the peak growth by body height and arm span measurements and the 
peak curve progression (Table 2) in each individual. All of these individuals thus were Risser 
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Stage 0 and premenarchal at baseline. By this method, any time lag between peak growth and 
peak curve progression will be determined. For this group, 56.5% were observed only and the 
remaining patients were braced. The mean Cobb angle at baseline for this group was 21° ± 4°, 
similar to the main cohort as described above. There were no differences between girls (21° ± 4°) 
and boys (21° ± 5°) (p > 0.05). 
Body height and arm span measured in centimeters, coronal Cobb angle magnitude, Risser stage, 
and DRU grades were recorded at each visit. DRU grades were based on the simplified DRU 
classification, which was tested and validated [5, 6] and was shown to be accurate in predicting 
peak growth by radius grade 6 (R6) and ulna grade 5 (U5), and growth cessation by radius grade 
9 (R9) and ulna grade 7 (U7) [4]. All data were recorded by two independent readers (JC and 
PC) blinded to the patient details. An average score of the Cobb angle was recorded if the 
measured degrees were within 5°. Any deviation beyond this and discrepancies with other 
measurements were decided by consensus between JC and PC. Age of menarche was listed for 
girls. For patients who were only observed and did not receive any treatment, the data were 
recorded every 4 to 5 months until skeletal maturity. For patients who ultimately were treated 
with bracing or surgery, only data before the intervention were recorded for analysis to keep the 
natural history data clean. All Cobb angles were measured on a standing posteroanterior whole-
spine radiograph. The major curve Cobb angle was used for progression analysis. The same 
radiograph was used for grading the Risser stage (United States version) [1]. All radiographic 
measurements were performed by spine surgeons as part of routine consultations and 
independent of the clinical parameters.  
Statistical Analysis 
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Descriptive statistics including the mean and SD of the growth rate (based on body height and 
arm span) and the curve progression rate then were calculated for each DRU grade. Based on 
DRU grades, the growth and curve progression rates were studied. The growth rate was 
calculated by the change in body height and arm span with time (months) between appointments. 
The DRU was assessed at the preceding visit and the change to the subsequent visit was 
calculated. At the same visits, curve progression rate was calculated by the change in Cobb angle 
with time (months). Shapiro-Wilk analysis revealed that age parameters were normally 
distributed but DRU grades were not. Therefore, a comparison was performed using a paired t-
test for age and the Wilcoxon signed-rank test for DRU grades. Spearman’s correlation 
coefficient was used to analyze the strength and direction of any association between the growth 
rate and the rate of curve progression. Data analyses were conducted using SPSS for Windows 
Version 23.0 (IBM SPSS Inc, Armonk, NY, USA). A p value less than 0.05 was considered 
statistically significant. Ninety-five percent confidence intervals were listed when appropriate to 
assess precision.  
Results 
Based on the overall cohort, there was correlation between growth rate and curve progression 
rate for body height (r = 0.26; p < 0.001) and arm span (r = 0.26; p < 0.001). Peak growth for 
body height occurred at R6 (0.56 ± 0.29 cm/month) and U4 (0.65 ± 0.31 cm/month); peak 
change in arm span occurred at R5 (0.67 ± 0.33 cm/month) and U3 (0.67 ± 0.22 cm/month); and 
peak curve progression matched with R7 (0.80 ± 0.89 cm/month) and U5 (0.84 ± 0.78 
cm/month) (Table 3). 
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There was a lag in curve progression as compared with the growth rate (Table 2). The peak curve 
progression was one DRU grade behind peak growth by body height and arm span, consistent for 
both girls and boys. This amounted to a lag of an average 7.2 months (girls: 8 months, boys: 6.8 
months) for body height and 7 months (girls: 8 months, boys: 6.4 months) for arm span. Looking 
at the overall cohort (Fig. 2), a similar lag was observed regarding the peak growth and curve 
progression rates. At the peak curve progression, the growth rates are already in the deceleration 
phase for R7 (0.31 ± 0.21 cm/month for body height and 0.39 ± 0.24 cm/month for arm span) 
and U5 (0.53 ± 0.27 cm/month for body height and 0.58 ± 0.36 cm/month for arm span). 
Similarly, the curve progression rates were lower than at its peak for the peak growth rate for 
body height (0.71° ± 0.69°/month for R6 and 0.44° ± 0.42°/month for U4) and arm span (0.51° ± 
0.58°/month for R5 and 0.39° ± 0.50°/month for U3).  
The mean time elapsed between the peak curve progression rate and the plateau phase at R9 U7 
was 16 ± 8 months based on body height and 17 ± 8 months based on arm span. This 
corresponded to two DRU grades. The curve progression rates appeared to be similarly reduced 
to the growth rate at R9 and U7 where all rates began to plateau. These findings were similar for 
both body height and arm span.  
Discussion 
The ability to predict which patients with AIS undergo curve progression and how curve 
progression can be predicted by growth is still limited. Decision-making is based on the 
clinician’s experience, the patient’s growth rate, and Cobb angle on presentation [11, 22]. 
Accurate prediction of a patient’s growth rate and risk of curve progression are crucial in 
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determining the best time to intervene. Indiscriminate or prolonged bracing, for example, may be 
associated with deleterious effects including reduced spinal mobility, poor body image and self-
esteem, and worse quality of life [7, 8, 15, 16, 25, 26]. Once bracing is initiated, it is continued 
until skeletal maturity because there is no way of knowing whether the scoliosis is 
nonprogressive or that the brace is actually preventing curve progression. It therefore is 
necessary to correlate the curve progression of AIS with natural growth to refine our 
understanding of the period of actual curve progression risk so that interventions can be provided 
in a timely manner and only for patients who really need it. As such, in this study we used a 
consistent and reproducible skeletal growth parameter to identify the relationship between the 
growth rate with the curve progression rate at its peak and plateau for our patients with scoliosis. 
Using standardized skeletal maturity parameters is necessary for this analysis because 
chronologic age has been shown to be inconsistent, with large interethnic variations and timing 
of the growth spurt. Variation of up to 4 years has been reported with chronologic age [17]. Our 
study results suggest that the DRU grades have a strong relationship with growth and curve 
progression rates. The peak curve progression rate was found to lag behind peak growth by 
approximately 7 months and the period of curve progression risk can extend to approximately 
1.5 years after peak growth.  Therefore, we have identified a mismatch between growth and 
curve progression rates.  
There are several inherent limitations to this study. As discussed earlier, body height and arm 
span were used as growth parameters. Specific vertebral body height measures should be studied 
to provide the most accurate growth indicator. Nevertheless, body height and arm span are still 
valuable as indirect growth parameters and are easily obtained even in a busy clinic. In addition, 
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this study is devoid of in-brace data for patients undergoing bracing. Although this methodology 
of excluding data from patients who underwent bracing or surgery eliminates potential 
interventional confounders, we cannot determine whether the effective bracing period coincides 
with our determined curve progression risk period. An additional focus study is required to 
address this gap. This study also is based on a homogenous southern Chinese population. These 
findings should be validated in other ethnicities. However, the homogeneous nature of the 
population further decreases any potential for ethnic-specific confounding that can further affect 
the interpretation of the findings. Finally, even with our relatively closely spaced DRU 
measurements every 4 to 5 months, it still might not capture the absolute peak. However, the 
value of this study is to identify a mismatch between growth and curve progression rates which 
has been achieved.  
Our subgroup analysis showed a relationship between the DRU grades and the growth and curve 
progression rates (Table 2). Having a validated and standardized maturity scale is crucial for 
determining which patients have remaining growth potential and may benefit from bracing. 
Many parameters like the Risser sign have been used to predict peak height velocity focused on 
long bone growth [4, 10, 17, 18, 19, 24]. However, the correlations between these growth 
parameters with curve progression risk are variable. The limited utility can be explained by 
inaccuracies with height measurements, the retrospective nature of determining peak height 
velocity, lack of ease of use and standardized growth measurements, and interpretation 
difficulties and inaccuracies with the Tanner-Whitehouse III maturity parameter and Risser 
stage. The DRU grades have been shown to be superior to the Risser stage, age of menarche, and 
metacarpal and phalangeal complexes in terms of growth prediction [4]. In the current study, we 
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determined its utility in measuring curve progression risk as well.  
Peak curve progression occurs approximately 7 months after the peak growth rate for body 
height and arm span measurements, based on our subgroup analysis. This suggests that peak 
height velocity occurs during the curve acceleration phase “just before” rather than “at” the peak 
curve progression period. The relationship between peak curve progression and peak height 
velocity is particularly important. A disjunction between growth and curve progression rates was 
suggested in previous studies [20, 22], but not fully quantified or put into clinical relevance. The 
peak height velocity noted in our study was slightly earlier (approximately one DRU grade) than 
what has been reported [4]. However, the findings were not confounded or influenced by 
interventions such as bracing, because data regarding such modalities initially were excluded 
from our study.  Therefore, it was possible for these patients to have even more rapid height gain 
during treatment, which was not included in our analysis because we only included data up to the 
point of initiating intervention. Nevertheless, we were able to capture summits (inclusive of an 
acceleration and deceleration phase) for growth and curve progression indicating that the data 
were near if not at the peak. This study shows the timing of peak curve progression does not 
match the peak height velocity and in fact the maximal curve progression occurs after the peak 
growth spurt, suggesting that any treatment such as bracing is still relevant after peak height 
velocity owing to this mismatch. This may be explained by the distal-to-proximal growth 
gradient which has been established, suggesting that more distal body parts like the foot reach 
the pubertal growth spurt earlier [23]. Busscher et al. [2] echoed this finding, showing that the 
timing of peak growth velocities differs with foot length occurring earliest at approximately 11 
years of age for girls, followed by the subischial leg length, total body height, and finally sitting 
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height at 12 years of age. For scoliosis management, standing height is a useful representation of 
overall growth, but because it incorporates the lower limbs, pelvis, and the skull, it may not be as 
sensitive for monitoring spine growth in managing deformity as the sitting height, which 
eliminates the contribution of the lower limbs. In this study, with our use of body height with 
arm span for measuring growth rate, the growth data may be more representative of long bone 
growth rather than spine growth. Arm span is useful in patients with scoliosis because curve 
deterioration may cause a reduction in overall height and thus mask the actual spine growth 
achieved [4]. Nevertheless, the correlation between these two measurements is near identical so 
body height and arm span changes are representative [3]. As such, it can be deduced that the 
earlier finding of peak growth can be contributed by our use of standing body height and arm 
span rather than sitting height because the lower limbs reach peak height velocity earlier than the 
spine. However, sitting height is still an indirect measure of spine growth and actual 
measurements of individual vertebral height gains, especially areas not affected by scoliosis, may 
be more accurate for this purpose. Standing body height and sitting height may be affected by 
increased curve magnitude. Data regarding the pattern of vertebral growth are lacking and should 
be addressed in a future study. Another potential reason for the mismatch between growth and 
curve progression may be related to variable responses of a spinal deformity to growth. Skeletal 
growth may not be the sole determinant of curve progression because up to 42% of patients 
during the adolescent growth spurt do not experience substantial curve progression [28]. The 
curve magnitude also may be related to the rate of curve progression. Larger curve magnitudes 
may behave differently than smaller curves. Moreover, several morphologic characteristics like 
rotational deformity or vertebral wedging have been studied to differentiate the patients with AIS 
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who are progressive [14].  Therefore, it is possible that despite a close relationship between 
growth and curve progression peak rates, some spine deformities do not deteriorate with growth 
and may be attributed to genetic or environmental influences. 
Based on the patients followed until skeletal maturity, the period of curve progression risk 
extends to nearly 1.5 years, even after peak growth has been achieved. This was determined as 
the relevant curve progression period because no additional progression was observed once 
patients reached a maturity status of R9 and U7. This finding correlates closely with growth as 
indicated by the matching troughs of growth and progression rates. Taking our findings into 
consideration, clinicians can decide when is the best time to wean bracing. However, as this is 
not a bracing intervention study, whether this relationship is true requires a dedicated study 
regarding brace weaning. The period between the peak curve progression at R7 and U5 to the 
beginning of a plateau phase seen for growth and curve progression at R9 and U7 was 
approximately 16 to 17 months. This information may provide clinicians with valuable 
information for counseling patients and their families, which is also an important component to 
reduce anxiety and even improve compliance [12]. 
Understanding the relationship between growth and curve progression rates based on a 
standardized maturity scale such as the DRU is a novel concept highlighted in this study. There 
is consistent mismatch between growth and curve progression rates when assessed by body 
height or arm span, and peak curve progression lags approximately 7 months behind peak 
growth. Therefore the curve should be monitored closely even after peak growth, and effective 
bracing does not only pertain to the period at or before the peak height velocity but even after. 
Furthermore, the period of actual curve progression risk has been determined to be 
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approximately 1.5 years; thereby, growth and curve progression rates simultaneously reduce to a 
plateau phase. This study has great value in providing practitioners who treat patients with 
scoliosis with better understanding of the relationship between curve progression risk and growth 
rate. This new information provides us with better tools to design more appropriate bracing 
protocols for patients with AIS.  
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Legend 
Fig. 1 The diagram shows how patients were included for the main cohort and subgroup 
analyses. 
Fig. 2A-B The graphs show the relationship between curve progression rate and growth rate 
(body height and arm span) plotted with (A) radius and (B) ulna grades. They indicate that the 
peak curve progression rate occurs after the peak growth rate. Curve progression and growth 
rates reduced to a plateau at R9 and U7. 
 
